Point72 »

Skye Bioscience shares owned by Point72

Quarter-by-quarter ownership of Skye Bioscience (SKYE) shares owned by Point72 from 13F filings

Historical chart of Point72 investment in Skye Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Skye Bioscience held by Point72 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Skye Bioscience by Point72

Quarter filed Position value Share count Share price at filing
2024-06-30 $48k 6.0k 8.01

More positions owned by Point72

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Apple (AAPL)
Pfizer (PFE)
Adobe Systems Incorporated Call Option (ADBE)
Amgen Call Option (AMGN)
salesforce Call Option (CRM)
Bristol Myers Squibb (BMY)
Amazon (AMZN)
Raytheon Technologies Corp (RTX)
NVIDIA Corporation (NVDA)
Thermo Fisher Scientific (TMO)
Visa Com Cl A (V)
Spotify Technology S A SHS (SPOT)
Eli Lilly & Co. Call Option (LLY)

View all positions for Point72

Top funds holding Skye Bioscience

5AM Venture Management
Versant Venture Management
Altium Capital Management
Logos Global Management
Sphera Funds Management
BlackRock
Henderson Group
Vanguard Group
CVI Holdings
Driehaus Capital Management
Point72 Asset Management
Baker Bros. Advisors
Perceptive Advisors
Schonfeld Strategic Advisors
Geode Capital Management

View all funds holding Skye Bioscience